Wenying Jian

2.2k total citations
55 papers, 1.5k citations indexed

About

Wenying Jian is a scholar working on Molecular Biology, Spectroscopy and Immunology. According to data from OpenAlex, Wenying Jian has authored 55 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 17 papers in Spectroscopy and 10 papers in Immunology. Recurrent topics in Wenying Jian's work include Protein purification and stability (10 papers), Biosimilars and Bioanalytical Methods (10 papers) and Advanced Proteomics Techniques and Applications (9 papers). Wenying Jian is often cited by papers focused on Protein purification and stability (10 papers), Biosimilars and Bioanalytical Methods (10 papers) and Advanced Proteomics Techniques and Applications (9 papers). Wenying Jian collaborates with scholars based in United States, China and Switzerland. Wenying Jian's co-authors include Naidong Weng, Xiuzhu Dong, Richard W. Edom, Lijuan Kang, Lin Zhu, Yaodong Xu, Ian A. Blair, Ling Dong, Xuhan Liu and Xin Yu and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Blood.

In The Last Decade

Wenying Jian

54 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenying Jian United States 23 812 354 214 173 136 55 1.5k
Cédric Delporte Belgium 22 914 1.1× 115 0.3× 118 0.6× 361 2.1× 114 0.8× 81 1.9k
Kazutaka Shimbo Japan 28 1.2k 1.5× 351 1.0× 49 0.2× 98 0.6× 208 1.5× 54 2.2k
Weina Gao China 20 746 0.9× 151 0.4× 60 0.3× 91 0.5× 84 0.6× 60 1.3k
Kathleen Carroll United Kingdom 13 1.4k 1.7× 283 0.8× 75 0.4× 107 0.6× 27 0.2× 24 2.0k
Henrianna Pang Canada 20 518 0.6× 82 0.2× 254 1.2× 234 1.4× 124 0.9× 26 1.6k
Shuhai Lin China 29 1.6k 1.9× 115 0.3× 43 0.2× 251 1.5× 71 0.5× 65 2.5k
Werner Rubas United States 18 613 0.8× 99 0.3× 73 0.3× 168 1.0× 61 0.4× 34 1.8k
Hang Zeng China 28 779 1.0× 215 0.6× 106 0.5× 155 0.9× 13 0.1× 54 1.9k
Mingxin Li China 22 426 0.5× 194 0.5× 37 0.2× 60 0.3× 47 0.3× 98 1.4k
Douglas M. Fast United States 18 320 0.4× 266 0.8× 125 0.6× 296 1.7× 52 0.4× 42 1.1k

Countries citing papers authored by Wenying Jian

Since Specialization
Citations

This map shows the geographic impact of Wenying Jian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenying Jian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenying Jian more than expected).

Fields of papers citing papers by Wenying Jian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenying Jian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenying Jian. The network helps show where Wenying Jian may publish in the future.

Co-authorship network of co-authors of Wenying Jian

This figure shows the co-authorship network connecting the top 25 collaborators of Wenying Jian. A scholar is included among the top collaborators of Wenying Jian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenying Jian. Wenying Jian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Yifan, Amanda Del Rosario, Shengping Wang, et al.. (2025). Measuring HSD17β13 protein turnover in mouse liver with D 2 O metabolic labeling and hybrid LC-MS. Bioanalysis. 17(3). 151–159.
2.
Jian, Wenying, et al.. (2025). Examining hybridization-based LC–MS methodologies for the bioanalysis of siRNA analytes. Bioanalysis. 17(16). 1041–1055. 1 indexed citations
3.
Ji, Shaofei, et al.. (2024). Comparison of multiple bioanalytical assay platforms for the quantitation of siRNA therapeutics. Bioanalysis. 16(13). 651–667. 5 indexed citations
4.
Kang, Lijuan, et al.. (2023). Evaluating the Use of Locked Nucleic Acid Capture Probes in Hybrid LC–MS/MS Analysis of siRNA Analytes. Bioanalysis. 15(18). 1129–1146. 8 indexed citations
5.
Shi, Yifan, et al.. (2022). Method Development Workflow for Quantifying Protein Biomarkers by Hybrid LC–MS/MS. Bioanalysis. 14(14). 985–1004. 7 indexed citations
6.
Khojasteh, S. Cyrus, Upendra A. Argikar, James P. Driscoll, et al.. (2021). Novel advances in biotransformation and bioactivation research – 2020 year in review. Drug Metabolism Reviews. 53(3). 384–433. 6 indexed citations
7.
Kang, Lijuan, Wilson B. Edwards, Raul C. Camacho, et al.. (2021). Application of Middle-Down Approach in Quantitation and Catabolite Identification of Protein by LC–high-Resolution Mass Spectrometry. Bioanalysis. 13(6). 465–479. 1 indexed citations
8.
Kellie, John F., John C. Tran, Wenying Jian, et al.. (2020). Intact Protein Mass Spectrometry for Therapeutic Protein Quantitation, Pharmacokinetics, and Biotransformation in Preclinical and Clinical Studies: An Industry Perspective. Journal of the American Society for Mass Spectrometry. 32(8). 1886–1900. 23 indexed citations
9.
Shi, Chuan, Shalom D. Goldberg, Vadim Dudkin, et al.. (2018). LC/MS/MS Bioanalysis of Protein–Drug Conjugates—The Importance of Incorporating Succinimide Hydrolysis Products. Analytical Chemistry. 90(8). 5314–5321. 13 indexed citations
10.
Wei, Cong, Dian Su, Jian Wang, Wenying Jian, & Donglu Zhang. (2018). LC–MS Challenges in Characterizing and Quantifying Monoclonal Antibodies (mAb) and Antibody-Drug Conjugates (ADC) in Biological Samples. Current Pharmacology Reports. 4(1). 45–63. 23 indexed citations
11.
Qiu, Xi, Lijuan Kang, Martin A. Case, Naidong Weng, & Wenying Jian. (2018). Quantitation of Intact Monoclonal Antibody in Biological Samples: Comparison of Different Data Processing Strategies. Bioanalysis. 10(13). 1055–1067. 23 indexed citations
12.
13.
Jian, Wenying, et al.. (2014). Recent advances in absolute quantification of peptides and proteins using LC-MS. Reviews in Analytical Chemistry. 33(1). 31–47. 22 indexed citations
14.
15.
Jian, Wenying, et al.. (2011). Evaluation of a High-Throughput Online Solid Phase Extraction–Tandem Mass Spectrometry System for In Vivo Bioanalytical Studies. Analytical Chemistry. 83(21). 8259–8266. 31 indexed citations
16.
Jian, Wenying, Richard W. Edom, Naidong Weng, et al.. (2010). Validation and application of an LC–MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma. Journal of Chromatography B. 878(20). 1687–1699. 49 indexed citations
17.
Jian, Wenying, Richard W. Edom, Yaodong Xu, & Naidong Weng. (2010). Recent advances in application of hydrophilic interaction chromatography for quantitative bioanalysis. Journal of Separation Science. 33(6-7). 681–697. 113 indexed citations
18.
Jian, Wenying, Richard W. Edom, Yaodong Xu, Joseph A. Gallagher, & Naidong Weng. (2010). Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC–MS/MS quantitation of metabolites. Journal of Chromatography B. 878(31). 3267–3276. 24 indexed citations
19.
Zhu, Peijuan, Wenying Jian, & Ian A. Blair. (2009). A 4-oxo-2(E)-nonenal-derived glutathione adduct from 15-lipoxygenase-1-mediated oxidation of cytosolic and esterified arachidonic acid. Free Radical Biology and Medicine. 47(7). 953–961. 8 indexed citations
20.
Jian, Wenying & Xiuzhu Dong. (2002). Transfer of Bifidobacterium inopinatum and Bifidobacterium denticolens to Scardovia inopinata gen. nov., comb. nov., and Parascardovia denticolens gen. nov., comb. nov., respectively.. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 52(3). 809–812. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026